Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

8.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.2K
3.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential biomarkers of Ewing sarcoma identified through a Europe-wide analysis of prospectively collected samples.

Scientific reports·2026
Same author

Intrinsic immune properties of carrier MSC impact on the clinical outcome of children with solid tumors receiving oncolytic virotherapy.

Experimental hematology & oncology·2026
Same author

Chitosan- and Gelatin-Based Composite Granular Hydrogels for Cartilage Tissue Regeneration.

International journal of molecular sciences·2026
Same author

Unaltered NKG2D-CAR T cell function under hypoxia in osteosarcoma in vitro.

Cancer immunology, immunotherapy : CII·2026
Same author

Hippo signalling pathway mediates oncogenic properties of NAB2::STAT6 in solitary fibrous tumour.

Cellular oncology (Dordrecht, Netherlands)·2026
Same author

Modeling the chondrocyte-derived osteoblasts formation process reveals its molecular signature and regulation network.

Bone research·2026

Related Experiment Video

Updated: Apr 13, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.8K

Bone microenvironment signals in osteosarcoma development.

Arantzazu Alfranca1, Lucia Martinez-Cruzado, Juan Tornin

  • 1Unidad de Biotecnología Celular, Área de Genética Humana, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.

Cellular and Molecular Life Sciences : CMLS
|May 4, 2015
PubMed
Summary
This summary is machine-generated.

Osteosarcoma (OS) initiation and progression are influenced by the bone microenvironment (BME). Understanding OS cell and BME interactions is crucial for effective cancer therapy.

More Related Videos

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.7K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.5K

Related Experiment Videos

Last Updated: Apr 13, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.8K
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.7K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.5K

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Bone homeostasis relies on intricate cellular interactions and regulated remodeling processes.
  • Osteosarcoma (OS) originates from poorly understood oncogenic events in bone cells.
  • The bone microenvironment (BME) plays a significant role in OS initiation and progression.

Purpose of the Study:

  • To review the physiological processes governing bone homeostasis.
  • To summarize current knowledge on OS cell and BME communication.
  • To elucidate how these interactions impact OS growth, metastasis, and treatment outcomes.

Main Methods:

  • Literature review of bone physiology and osteosarcoma research.
  • Analysis of cellular and molecular interactions within the BME.
  • Synthesis of data on OS cell behavior and therapeutic responses.

Main Results:

  • Bone homeostasis is maintained by a balance of cell proliferation, differentiation, and apoptosis.
  • The BME provides signals that influence OS cell growth, invasion, and stemness.
  • Interactions between OS cells and the BME affect treatment efficacy.

Conclusions:

  • The BME is a critical regulator of osteosarcoma development and progression.
  • Targeting OS cell-BME interactions presents a promising therapeutic strategy.
  • Further research into these interactions can improve patient outcomes.